Paper4581906
Late toxicity to hydralazine resembling systemic lupus erythematosus or rheumatoid arthritis.
Perry HM. Am J Med, 1973. Cited by 336 papers, by iCite.
Cite this record
ConductScience Library. Late toxicity to hydralazine resembling systemic lupus erythematosus or rheumatoid arthritis. Papers, record 4581906. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/4581906
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
- Title
- Late toxicity to hydralazine resembling systemic lupus erythematosus or rheumatoid arthritis.
- PubMed
Topics21
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| Arthritis, Rheumatoid | Major topic |
| Drug Hypersensitivity | Major topic |
| Hydralazine | Major topic |
| Lupus Erythematosus, Systemic | Major topic |
| Acetylation | |
| Adult | |
| Antibodies, Antinuclear | |
| Antigen-Antibody Reactions | |
| Blood Pressure | |
| DNA | |
| Diagnosis, Differential | |
| Female | |
| Fever | |
| Follow-Up Studies | |
| Humans | |
| Hypertension | |
| Male | |
| Polymorphism, Genetic | |
| Seasons | |
| Syndrome | |
| Time Factors |
Source PubMed
Cited by66
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 336 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 40632154 | The change in the pharmacological significance of dihydralazine (Germany) and hydralazine (USA). | Naunyn Schmiedebergs Arch Pharmacol | 2026 | https://conductscience.org/library/papers/40632154 | PubMed |
| 32953340 | A Case of Seronegative ANA Hydralazine-Induced Lupus Presenting With Pericardial Effusion and Pleural Effusion. | Cureus | 2020 | https://conductscience.org/library/papers/32953340 | PubMed |
| 22454932 | Acetylation of procaine amide in man studied with a new gas chromatographic method. | Br J Clin Pharmacol | 1974 | https://conductscience.org/library/papers/22454932 | PubMed |
| 20544243 | Acrylamine-induced autoimmune phenomena. | Clin Rheumatol | 2010 | https://conductscience.org/library/papers/20544243 | PubMed |
| 18489081 | Procainamide, but not N-acetylprocainamide, induces protein free radical formation on myeloperoxidase: a potential mechanism of agranulocytosis. | Chem Res Toxicol | 2008 | https://conductscience.org/library/papers/18489081 | PubMed |
| 8535929 | Drug-induced "allergic hepatitis". | Clin Rev Allergy Immunol | 1995 | https://conductscience.org/library/papers/8535929 | PubMed |
| 8435078 | Effect of thiol compounds on human complement component C4. | Biochem J | 1993 | https://conductscience.org/library/papers/8435078 | PubMed |
| 8396914 | Arylamine N-acetyltransferase activity in human cultured cell lines. | Biochem J | 1993 | https://conductscience.org/library/papers/8396914 | PubMed |
| 7946001 | Adverse effects of direct-acting vasodilators. | Drug Saf | 1994 | https://conductscience.org/library/papers/7946001 | PubMed |
| 7516856 | Selecting appropriate antihypertensive drug dosages. | Drugs | 1994 | https://conductscience.org/library/papers/7516856 | PubMed |
| 7427242 | Hydrallazine-induced lupus erythematosus-like syndrome in a patient of the rapid acetylator phenotype. | Br Med J | 1980 | https://conductscience.org/library/papers/7427242 | PubMed |
| 7357301 | Hydrallazine-induced cutaneous vasculitis. | Br Med J | 1980 | https://conductscience.org/library/papers/7357301 | PubMed |
| 7314046 | Hydralazine lung. | Thorax | 1981 | https://conductscience.org/library/papers/7314046 | PubMed |
| 7259927 | Further evidence for an acetylator phenotype difference in the metabolism of hydralazine in man. | Br J Clin Pharmacol | 1981 | https://conductscience.org/library/papers/7259927 | PubMed |
| 7205989 | Acute low-dose hydralazine induced lupus syndrome (HILS). | J Natl Med Assoc | 1981 | https://conductscience.org/library/papers/7205989 | PubMed |
| 7202470 | A clinical and pharmacokinetic evaluation of tolmesoxide in hypertensive patients. | Eur J Clin Pharmacol | 1981 | https://conductscience.org/library/papers/7202470 | PubMed |
| 7191632 | Mercaptopurine pharmacogenetics: monogenic inheritance of erythrocyte thiopurine methyltransferase activity. | Am J Hum Genet | 1980 | https://conductscience.org/library/papers/7191632 | PubMed |
| 7047041 | Clinical pharmacokinetics of hydralazine. | Clin Pharmacokinet | 1982 | https://conductscience.org/library/papers/7047041 | PubMed |
| 7021123 | Adverse effects of antihypertensive drugs. | Drugs | 1981 | https://conductscience.org/library/papers/7021123 | PubMed |
| 7011656 | Acetylator phenotype and lupus erythematosus. | Clin Pharmacokinet | 1981 | https://conductscience.org/library/papers/7011656 | PubMed |
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Grants
- Trials
- Comments and corrections
- References
- Genes
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/4581906
GET https://conductscience.org/api/papers/v1/4581906/cited_by?page=2